Related MeSH Hierarchy (4)
Diseases [C] » Infections [C01] » Urinary Tract Infections
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urologic Diseases » Urinary Tract Infections
Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases » Urinary Tract Infections
Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Urinary Tract Infections
Description
Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. MeSH
Hierarchy View
Subtype Terms (3)
Bacteriuria
16 drugs (12 approved, 4 experimental)
Pyuria
1 experimental drug
Schistosomiasis haematobia
14 drugs (7 approved, 7 experimental)
Approved Indicated Drugs (73)
Phase 4 Indicated Drugs (41)
Phase 3 Indicated Drugs (26)
Phase 2 Indicated Drugs (23)
Phase 1 Indicated Drugs (8)
Other Experimental Indicated Drugs (26)
Organization Involved with Phase 4 Indications (138)
Addis Continental Institute of Public Health
American Urogynecologic Society
Amhara Public Health Institute
Babol University of medical scienses
Bangabandhu Sheikh Mujib Medical University
Case Western Reserve University
Chengdu University of Traditional Chinese Medicines
China Academy of Chinese Medical Sciences
French National Network of Clinical Research in Infectious Diseases
Fundação Educacional Serra dos Órgãos
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Gillette Children's Specialty Healthcare
Guangdong Provincial Hospital of Traditional Chinese Medicine
Hubei University of Chinese Medicine
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Katholieke Universiteit Leuven
Laboratorios Senosiain, S.A. de C.V.
Mashhad University of Medical Sciences
Moorgreen Hospital, Southampton
National Institute of Allergy and Infectious Diseases (NIAID)
National University of Ireland
NHS Health Technology Assessment Programme
Shanghai University of Traditional Chinese Medicine
Sint Antonius Hospital, Nieuwegein
Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction
St. Antonius Hospital, Nieuwegein
State University of New York, Buffalo
Sunnaas Rehabilitation Hospital
Swiss Paraplegic Centre Nottwil
Swiss Spinal Cord Injury Cohort Study (SwiSCI)
Universidad Autonoma de Barcelona
Universidad Complutense de Madrid
Universidad del Norte, Barranquilla
Université catholique de Louvain
University of British Columbia
Organization Involved with Phase 3 Indications (82)
Ajanta Hospital and Research Centre
All India Institute of Medical Sciences
Assistance Publique - Hôpitaux de Paris
Children's National Medical Center
Christian Medical College, Vellore, India
Deenanath Mangeshkar Hospital & Research Centre
Department of Health and Human Services
Groupe Hospitalier Paris Saint Joseph
King George's Medical University
K.L.E.S Dr. Prabhakar Kore Hospital & Medical research Centre
MV Hospital and Research Center
National Center for Complementary and Integrative Health (NCCIH)
National Cheng Kung University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Northeast Ohio Medical University
Om Surgical Centre and Maternity Home
Postgraduate Institute of Medical Education and Research
Sapthagiri Institute of Medical Sciences and Research Center (SIMSRC)
Sher-i-Kashmir Institute of Medical Sciences (SKIMS)
Sihuan Pharmaceutical Holdings Group Ltd.
Organization Involved with Phase 2 Indications (43)
Buckinghamshire Healthcare NHS Trust
Canadian Urological Association
Justus Liebig University Giessen
Kirov Military Medical Academy
Mississippi Medical Research, LLC
Pharmaceutical Research Associates, Inc. (PRA)
Philipps University of Marburg
Pirogov Russian National Research Medical University
Pokrovskaya Hospital, St. Petesburg, Russia
Russian Academy of Medical Sciences
Saint-Petersburg State Budgetary Healthcare Institution "City Clinical Hospital No. 31"
Scientific and Research Center "Eco-Safety"
Organization Involved with Phase 1 Indications (16)
Organization Involved with Other Experimental Indications (31)
Academic Medical Organization of Southwestern Ontario
Beijing Institute of Disease Control and Prevention
Commonwealth Scientific and Industrial Research Organisation, Australia
Hamilton Health Sciences Corporation
Hospital General Dr. Manuel Gea Gonzalez
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
